The U.S. health secretary and the Food and Drug Administration (FDA) chief, Marty Makary, are in a power struggle over the procedures for conducting vaccine safety studies. The disagreement centers on the optimal approach to assessing vaccine safety, with the health secretary advocating for a more rigorous and comprehensive methodology, while the FDA chief supports a more streamlined process.
This clash highlights the complexities of balancing vaccine safety with the need for expedited approval processes, particularly in light of the ongoing public health crisis. The disagreement has raised concerns about the potential impact on public trust in the vaccine safety protocols.